Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 4/20 | 0.33 |
| ▸ | PTGIR | P43119 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3463067 | 0.84 | PTGIR (0.33) | MEN1GAAKMT2ASMN1; SMN2CNR2 | |
| SCHEMBL6515405 | 0.84 | PTGIR (0.33) | MEN1GAAKMT2ASMN1; SMN2CNR2 | |
| SCHEMBL4623301 | 0.83 | PTGIR (0.34) | MEN1GAAKMT2ASMN1; SMN2CNR2 | |
| SCHEMBL4623306 | 0.83 | PTGIR (0.34) | MEN1GAAKMT2ASMN1; SMN2CNR2 | |
| SCHEMBL6411933 | 0.83 | PTGIR (0.34) | MEN1GAAKMT2ASMN1; SMN2CNR2 | |
| SCHEMBL424401 | 0.79 | CNR2 (0.33) | MEN1GAAKMT2ASMN1; SMN2CNR2 | |
| SCHEMBL424400 | 0.79 | CNR2 (0.33) | MEN1GAAKMT2ASMN1; SMN2CNR2 | |
| SCHEMBL7995297 | 0.69 | ALDH1A1 (0.34) | MEN1GAAKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL7972362 | 0.69 | ALDH1A1 (0.34) | MEN1GAAKMT2ASMN1; SMN2KDM4E | |
| SCHEMBL7972305 | 0.64 | ALDH1A1 (0.32) | MEN1GAAKMT2ASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120021911-A1 | Plant Treatment Compositions and Methods for Their Use | GOWAN CO. (US) | 2012-01-26 | — | — | US | disclosed |
| EP-2403336-A1 | PLANT TREATMENT COMPOSITIONS AND METHODS FOR THEIR USE | Gowan Co. (US) | 2012-01-11 | — | — | EP | disclosed |
| US-20110218106-A1 | PLANT TREATMENT COMPOSITIONS PARTICULARLY EFFECTIVE IN THE CONTROL OF HETERANTHERAL LIMOSA ON RICE CROPS, AND METHODS FOR THEIR USE | GOWAN CO. (US) | 2011-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110218106-A1 | PLANT TREATMENT COMPOSITIONS PARTICULARLY EFFECTIVE IN THE CONTROL OF HETERANTHERAL LIMOSA ON RICE CROPS, AND METHODS FOR THEIR USE | TRHDE, DDT, HPD | MEN1 4747/4885GAA 1953/4885KMT2A 1157/4885 |
| US-20120021911-A1 | Plant Treatment Compositions and Methods for Their Use | ALG1, DDT, ALG3 | MEN1 2207/4885GAA 14/4885KMT2A 396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.